Renowned Cancer Researcher to Direct MUSC's Hollings Cancer Center
CHARLESTON, SC – The Medical University of South Carolina has named Gustavo W. Leone, Ph.D., director of the Hollings Cancer Center (HCC). His appointment to South Carolina’s only National Cancer Institute-designated (NCI) center begins March 1, 2017. In addition to his strong leadership background, Leone is a preeminent cancer research expert with a longstanding record of pursuing innovative and interdisciplinary approaches to cancer research while mentoring and supporting the next generation of cancer researchers.
“We are pleased to have recruited a leader and cancer researcher of Dr. Leone’s stature to guide the Hollings Cancer Center in this next phase of its growth,” said Lisa K. Saladin, Ph.D., MUSC interim provost. “He brings to MUSC the knowledge and experience to build on Hollings’ past successes and take the cancer center to the next level.”
As director, Leone will oversee the patient care arm of the Hollings Cancer Center as well as lead cancer-related research efforts in order to achieve and promote transdisciplinary and translational collaborative research. HCC includes more than 120 faculty-level cancer scientists with an annual research funding portfolio of $44 million. A primary goal for Leone will be to support and enhance the infrastructure key to the center’s prestigious NCI-designated status and to build programming and recruitment efforts to attain NCI Comprehensive Cancer Center status.
“I am excited about the many strengths and areas of great potential at the Hollings Cancer Center and MUSC,” said Leone, “I look forward to working with the faculty and staff to do all that we can to make a difference for cancer patients in South Carolina and to expand cutting-edge research in ways that will reduce the burden of cancer in South Carolina and beyond.”
Leone earned his doctoral degree from the University of Calgary and completed a postdoctoral fellowship at Duke University in 1998 before joining The Ohio State University (OSU) as an assistant professor at OSU’s NCI-designated James Comprehensive Cancer Center. Leone advanced to full professor in molecular genetics in 2011 and held the Klotz Chair in Cancer Research. In his leadership positions as director of the Solid Tumor Biology Program and associate director for basic research, he was instrumental in the rise of the James Comprehensive Cancer Center to the top tier of all cancer centers. Leone also expanded mentoring, recruitment, and collaborative research efforts as a founding member of the Pelotonia Fellowship Program in Cancer Research, with specific goals to train basic and translational researchers across the cancer continuum.
“Dr. Leone is an outstanding leader and cancer researcher who will surely elevate the Hollings Cancer Center to new heights,” said Raymond N. DuBois, M.D., Ph.D., dean of the MUSC College of Medicine and past president of the American Association for Cancer Research. DuBois, an active researcher and leader at three NCI-designated cancer centers prior to joining MUSC, added, “I look forward to working with Dr. Leone to further strengthen the Hollings Cancer Center, including the recruitment of additional cancer investigators to further accelerate the strong positive trajectory of the center.”
Leone will continue to conduct laboratory and translational research at MUSC, focusing on identifying how disruption of critical cell cycle regulatory pathways contributes to uncontrolled cell growth, a hallmark of cancer. Currently his laboratory group focuses on studying how genes outside the tumor cell affect the community of cells around a cancer cell, a research area that may reveal new cancer treatment strategies. He has authored more than 120 peer-reviewed publications and has received numerous recognitions for his contributions to cancer research. Mentoring the next generation of cancer researchers is a passion for Leone, who has an impressive track record of successful mentorship that includes not only numerous faculty but also hundreds of trainees ranging from college undergraduates to postdoctoral fellows.
About Hollings Cancer Center
The Hollings Cancer Center at the Medical University of South Carolina is a National Cancer Institute-designated Cancer Center and the largest academic-based cancer research program in South Carolina. The cancer center is comprised of more than 120 faculty-level cancer scientists with a research funding portfolio of $44 million and a dedication to reducing the cancer burden in South Carolina. Hollings offers state-of-the-art diagnostic capabilities, therapies and surgical techniques within multidisciplinary clinics that include surgeons, medical oncologists, radiation therapists, radiologists, pathologists, psychologists, and other specialists equipped for the full range of cancer care, including more than 200 clinical trials. For more information, please visit Hollings Cancer Center.
Founded in 1824, the Medical University of South Carolina (MUSC) continues the tradition of excellence in education, research and patient care. MUSC educates and trains more than 3,000 students and nearly 800 residents in six colleges and has more than 17,000 employees. As the state’s only integrated academic health sciences center and largest non-federal employer in Charleston, the university and its affiliates have collective annual budgets in excess of $3.2 billion, with an annual economic impact of nearly $4 billion and annual research funding in excess of $284 million.
As the clinical health system of the Medical University of South Carolina, MUSC Health is dedicated to delivering the highest quality patient care available, while training generations of competent, compassionate health care providers to serve the people of South Carolina and beyond. Comprising some 1,600 beds, more than 100 outreach sites, the MUSC College of Medicine, the physicians’ practice plan, and nearly 275 telehealth locations, MUSC Health owns and operates eight hospitals situated in Charleston, Chester, Florence, Lancaster and Marion counties. In 2019, for the fifth consecutive year, U.S. News & World Report named MUSC Health the No. 1 hospital in South Carolina.